8 Osteoporosis: pathogenesis, diagnosis, prevention and management

https://doi.org/10.1016/S0950-351X(05)80274-5Get rights and content

Summary

Osteoporosis has emerged as a major and increasing health problem requiring interventions at both the individual and community levels. Most cases of osteoporosis are found among women after the menopause, since menopausal status and age are key predictors of fracture risk. This review has focused particularly on osteoporosis occurring in postmenopausal women: the magnitude of the problem, how it occurs, how it is diagnosed, strategies in prevention and treatment. The diagnosis of osteoporosis and identification of individuals with heightened fracture risk due to osteopenia have been greatly facilitated by the development of dual energy X-ray absorptiometry, a simple, safe, highly precise technique for bone density measurement.

Where possible, intervention strategies in osteoporosis have been related to what is known about the pathogenesis of bone loss, especially the management of modifiable risk factors. Oestrogen deficiency of any cause results in accelerated bone turnover, with an increase in the rate of net bone loss. Exogenous oestrogens can control this form of bone loss. In established osteoporosis, hormone replacement therapy can achieve clinically-significant gains in bone mass. Consideration of hormone replacement therapy is pivotal in preventive and therapeutic strategies. Issues other than osteoporosis must be taken into account when hormone replacement is considered. Attention to other modifiable risk factors, both in the lifestyle and of a medical nature, is also indicated.

A number of promising agents for the treatment of established osteoporosis are described. However, available data on fracture prevention by these agents are limited. There is concern that an ideal therapy for established osteoporosis may not be achievable. Therefore, strong emphasis is placed on the need for osteoporosis prevention now and in the foreseeable future. Although much has been learnt in recent years, more research is needed in the long-term prediction of fracture risk, broadly-applicable measures to reduce the prevalence of osteoporosis, and targeted interventions for individuals at high risk.

References (141)

  • LangP et al.

    Osteoporosis. Current techniques and recent developments in quantitative bone densitometry

    Radiologic Clinics of North America

    (1991)
  • MacIntyreI et al.

    Calcitonin for prevention of postmenopausal bone loss

    Lancet

    (1988)
  • MamelleN et al.

    Risk—benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis

    Lancet

    (1988)
  • MarcusR

    Calcium intake and skeletal integrity: is there a critical relationship?

    Journal of Nutrition

    (1987)
  • MarcusR

    Skeletal aging. Understanding the functional and structural basis of osteoporosis

    Trends in Endocrinology and Metabolism

    (1991)
  • MatkovicV et al.

    Bone status and fracture rates in two regions of Yugoslavia

    American Journal of Clinical Nutrition

    (1979)
  • Mayo-SmithW et al.

    Radiographic appearance of osteopenia

    Radiologic Clinics of North America

    (1991)
  • OvergaardK et al.

    Discontinuous calcitonin treatment of established osteoporosis—effects of withdrawal of treatment

    American Journal of Medicine

    (1990)
  • ParfittAM

    Trabecular bone architecture in the pathogenesis and prevention of fracture

    American Journal of Medicine

    (1987)
  • AngusRM et al.

    Osteoporosis: the role of calcium intake and supplementation

    Medical Journal of Australia

    (1988)
  • Black SandlerR et al.

    Postmenopausal bone density and milk consumption in childhood and adolescence

    American Journal of Clinical Nutrition

    (1985)
  • BlockJE et al.

    Does exercise prevent osteoporosis?

    Journal of the American Medical Association

    (1987)
  • CannCE et al.

    Precise measurement of vertebral mineral content using computed tomography

    Journal of Computer Assisted Tomography

    (1980)
  • ChesnutCH

    Osteoporosis and its treatment

    New England Journal of Medicine

    (1992)
  • ChowR et al.

    Effect of two randomised exercise programmes on bone mass of healthy postmenopausal women

    British Medical Journal

    (1987)
  • ChristiansenC et al.

    17β-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

    Journal of Clinical Endocrinology and Metabolism

    (1990)
  • ChristiansenC et al.

    Prediction of rapid bone loss in postmenopausal women

    Lancet

    (1987)
  • CompstonJE

    Structural mechanisms of trabecular bone loss

  • CummingsSR

    Position papers. Bone mineral densitometry

    Annals of Internal Medicine

    (1987)
  • CummingsSR et al.

    Epidemiology of osteoporosis and osteoporotic fractures

    Epidemiologic Reviews

    (1985)
  • CummingsSR et al.

    Should prescription of postmenopausal hormone therapy be based on the results of bone densitometry?

    Annals of Internal Medicine

    (1990)
  • DavidsonRM et al.

    Multiple forms of mechanosensitive ion channels in osteoblast-like cells

    Pflügers Archiv. European Journal of Physiology (Berlin)

    (1990)
  • Dawson-HughesB et al.

    A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women

    New England Journal of Medicine

    (1990)
  • DelmasPD et al.

    Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis

    Journal of Bone and Mineral Research

    (1991)
  • DrinkwaterBL et al.

    Menstrual history as a determinant of current bone density in young athletes

    Journal of the American Medical Association

    (1990)
  • DudaRJ et al.

    Concurrent assays of circulating bone-gla protein and bone alkaline phosphatase: effects of sex, age and metabolic bone disease

    Journal of Clinical Endocrinology and Metabolism

    (1988)
  • Dure-SmithBA et al.

    Fluoride therapy for osteoporosis: a review of dose response, duration of treatment, and skeletal sites of action

    Calcified Tissue International

    (1991)
  • EastellR et al.

    Unequal decrease in bone density of lumbar spine and ultradistal radius in Colles' and vertebral fracture syndromes

    Journal of Clinical Investigation

    (1989)
  • EbelingPR et al.

    Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases

    Journal of Bone and Mineral Research

    (1992)
  • EismanJA

    Osteoporosis—prevention, prevention, prevention and prevention

    Australian and New Zealand Journal of Medicine

    (1991)
  • EpsteinS

    Serum and urinary markers of bone remodelling: assessment of bone turnover

    Endocrine Reviews

    (1988)
  • EriksenEF et al.

    Evidence of estrogen receptors in normal human osteoblast-like cells

    Science

    (1988)
  • FarleyJR et al.

    Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone forming cells

    Science

    (1983)
  • FarrugiaW et al.

    The effect of uninephrectomy on osteocalcin metabolism in sheep: a direct evaluation of renal osteocalcin clearance

    Journal of Endocrinology

    (1991)
  • FentonAJ et al.

    A potent inhibitor of osteoclastic bone resorption within a highly conservated pentapeptide region of parathyroid hormone-related protein; PTHrP[107–111]

    Endocrinology

    (1991)
  • FogelmanI et al.

    The bone scan in metastatic disease

  • FrostHM

    Treatment of osteoporosis by manipulation of coherent bone cell populations

    Clinical Orthopaedics and Related Research

    (1979)
  • GenantHK et al.

    Appropriate use of bone densitometry

    Radiology

    (1989)
  • GennariC et al.

    The effect of nandrolone decanoate therapy on bone loss in postmenopausal osteoporosis

  • GeusensP et al.

    Long-term effect of nandrolone decanoate, 1α-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study

    Bone and Mineral

    (1986)
  • Cited by (24)

    • Can gait kinetic data predict femoral bone mineral density in elderly men and women aged 50 years and older?

      2021, Journal of Biomechanics
      Citation Excerpt :

      In particular, hip fracture is a serious complication of osteoporosis related to high mortality, long-term disability, and loss of independence in the activities of daily living among the elderly, and the incidence of hip fracture increases rapidly with age (Willig et al, 2001; Melton, 1996). Bone mineral density (BMD) accounts for approximately 70% of bone strength, and is often used as a surrogate measure of bone strength and a predictor of fracture risk (Wark, 1993). It has been reported that bone tissue responds to dynamic loading while static loading does not initiate osteogenesis (Lanyon and Rubin, 1984).

    • The climacteric

      2004, Physiotherapy in Obstetrics and Gynaecology: Second Edition
    View all citing articles on Scopus
    View full text